Abstract
Thirty consecutive patients with germinal testis tumours were treated with combined-modality programme. Seven patients were entered in the surveillance protocol, 7 patients had irradiation of the paraaortic and ipsilateral pelvic lymph nodes, 16 patients were treated with four courses of chemotherapy. Of the patients 5 underwent surgical removal of residual masses.
After the combined-modality treatment 27 (90%) patients had complete remission, 2 patients showed progression on therapy and the other had incomplete resection of residual masses. After a median follow-up period of 41.5 months, 27 (90%) remain continuously disease-free, 2 patients died and one patient is still alive with his enlarged mediastinal lymph nodes.
The treatment policy stage by stage was defined by the current roles of surgery, irradiation and chemotherapy in our efforts.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ellis, M., Sikora, K.: The current management of testicular cancer.Br. J. Urol., 59, 2 (1987).
Peckham, M. J.: Management of nonseminomatous germ cell tumours of the testis: The Royal Marsden Hospital Experience. In: J. P. Donohue (ed.): Testis Tumours, 1st ed. Williams and Wilkins Co., Baltimore-London 1983, pp. 266–277.
Lowe, B. A.: Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage 1 nonseminomatous germ cell tumours.Urol. Clin. North Am., 20, 75 (1993).
Shipley, W. U.: Radiation therapy for patients with testicular and extragonadal seminoma. In: J. P. Donohue (ed.): Testis Tumours, 1st ed., Williams and Wilkins Co., Baltimore-London 1983, pp. 224–236.
Peckham, M. J., McElwain, T. J., Barrett, A.: Combined management of teratoma of the testis.Lancet, II, 267 (1979).
Ellis, M., Sikora, K.: Advances in the management of testicular cancer. In: G. Mathe (ed.): Therapeutic Trials in Oncology. Bioscience, Geneva 1985, pp. 150–172.
Nethersell, A., Drake, L., Sikora, K.: The increasing incidence of testicular cancer in East Anglia.Br. J. Cancer, 50, 377 (1984).
Klein, E. A.: Tumor markers in testis cancer.Urol. Clin. North Am., 20, 67 (1993).
Oliver, R. T. D., Hope-Stone, H. F., Blandy, J. P.: Justification for the use of surveillance in the management of stage 1 germ cell tumors of the testis.Br. J. Urol., 55, 760 (1983).
Wishnow, K. I., Johnson, D. E., Tenney, D.: Are lymphangiograms necessary before placing patients with non-seminomatous testicular tumors on surveillance.J. Urol., 141, 1133 (1989).
Freedman, L. S., Parkinson, M. C., Jones, W. G.: Histopathology in prediction of relapse of patients with stage 1 testicular teratoma treated by orchiectomy alone.Lancet, 2, 294 (1987).
Peckham, M. J., Barret, A., Liew, K. H.: The treatment of metastatic germ-cell tumors with bleomycin, etoposide and cisplatin (PEB).Br. J. Cancer, 47, 613 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lekili, M., Minareci, S., Nergis, N. et al. Management of testicular cancer with combined-modality treatment. International Urology and Nephrology 27, 423–429 (1995). https://doi.org/10.1007/BF02550078
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550078